Cibus, Inc. - 8-K Filing

Cibus, Inc. reports Q3 2026 results with $9.3 million net cash used in operations and updates on Rice and biofragrance programs. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:11 UTC

Tickers: $CBUS

Read the full article at SEC EDGAR

Part of the story Cibus, Inc. - 8-K Filing (3 articles)

More Regulatory news

Stark Novus Financial Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:44 UTC
Starling Oncology, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:43 UTC
Spero Therapeutics, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:43 UTC
BATTALION OIL CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 21:43 UTC
INNOVATIVE FOOD HOLDINGS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 21:42 UTC
Silexion Therapeutics Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:42 UTC
DiaMedica Therapeutics Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:42 UTC
BATTALION OIL CORP - 8-K Filing SEC EDGAR · November 12, 2026, 21:41 UTC
Algorhythm Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:42 UTC
AMERICAN BATTERY MATERIALS, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:41 UTC